Clinical Model Predicts Risk of Levodopa-induced Dyskinesia in Parkinson’s

Clinical Model Predicts Risk of Levodopa-induced Dyskinesia in Parkinson’s
Some clinical features of Parkinson’s disease patients — such as age at disease onset, disease duration, initial motor symptom, and use of dopaminergic agonists — can predict with high accuracy which patients will experience dyskinesia (abnormal involuntary movements) induced by levodopa treatment, a study found. The study, “Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease,” was published in the ... read more
Source: Parkinson’s News TodayPublished on 2020-04-21By Ines Martins, PhD